Xenon Pharmaceuticals, Inc. (XENE)
54.39
-1.61
(-2.88%)
USD |
NASDAQ |
May 15, 16:00
52.65
-1.74
(-3.20%)
Pre-Market: 20:00
Xenon Pharmaceuticals Total Assets (Quarterly) : 1.387B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | 724.00M |
| Alkermes Plc | 4.258B |
| Edesa Biotech, Inc. | 12.38M |
| ProMIS Neurosciences, Inc. | 67.41M |
| Tyra Biosciences, Inc. | 412.04M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 48.99M |
| Shareholders Equity (Quarterly) | 1.338B |
| Debt to Equity Ratio | 0.0056 |
| Current Ratio | 27.79 |
| Net Debt Paydown Yield | 0.01% |